Heterocyclic compounds with affinity to muscarinic receptors

Details Heterocyclic compounds with affinity to muscarinic receptors Heterocyclic compounds with affinity to muscarinic receptors

2008-04-23

2011-12-27

Andres, Janet L. (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S341000, C546S272100, C546S275400

Reexamination Certificate

active

08084473

ABSTRACT:
The present invention relates to heterocyclic compounds of the formula (I)or a pharmaceutically acceptable salt, a solvate or hydrate thereof.

REFERENCES:
patent: 6506747 (2003-01-01), Betageri et al.
patent: 0 259 621 (1988-03-01), None
patent: 0 296 721 (1988-12-01), None
patent: 0 316 718 (1989-05-01), None
patent: WO 03/037327 (2003-05-01), None
patent: WO 2006/070198 (2006-07-01), None
patent: WO 2008/129054 (2008-10-01), None
Del Giudice et al., Archiv der Pharmazie (Weinheim, Germany) (2003), 336(3), 143-154.
International Preliminary Report on Patentability for PCT/EP2008/054897 dated Jul. 24, 2009 (14 pages).
International Search Report for PCT/EP2008/054897 dated Mar. 12, 2008 (published as WO 2008/129054 A3 on Feb. 5, 2009) (9 pages).
Clemo, G.R. et al., “The Synthesis of Pyridylpyrazoles,”J. Chemical Society(1934), p. 1739, Beilstein Registry No. 15155.
Plate, R. et al., “Synthesis and In Vitro Muscarinic Activities of a Series of 3-(Pyrazol-3-y1)-1-azabicyclo[2.2.2]octanes,”Bioorganic&Medicinal Chemistry(2000), vol. 8, pp. 449-454.
Plate, R. et al., “Synthesis and Muscarinic Activities of 3-(PyrazolyI)-1,2,5,6-tetrahydyropyridine Derivatives,”Bioorganic&Medicinal Chemistry(1996), vol. 4, pp. 227-237.
Sauerberg, P. et al., “Novel Functional M1Selective Muscarinic Agonists. Synthesis and Structure Activity Relationships of 3-(1,2,5-Thiadiazolyl)-1,2,5,6-tetrahydro-1-methylpyridines,”J. Medicinal Chemistry(1992), vol. 35, pp. 2274-2283.
Ward, J.S. et al., “Novel Functional M1Selective Muscarinic Agonists. 2. Synthesis and Structure-Activity Relationships of 3-Pyraziny1-1,2,5,6-tetrahydro 1-methylpyridines. Construction of a Molecular Model for the M1Pharmacophore,”J. Medicinal Chemistry(1992), vol. 35, pp. 4011-4019.
Zlotos, D.P. et al., “Muscarinic Receptor Agonists and Antagonists,”Expert Opinion on Therapeutic Patents(1999), vol. 9, pp. 1029-1053.

Affiliated with

Also associated with

Rating

Heterocyclic compounds with affinity to muscarinic receptors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Heterocyclic compounds with affinity to muscarinic receptors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic compounds with affinity to muscarinic receptors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4257467